Privia Enterprise Value Over E B I T D A from 2010 to 2024
| PRVA Stock | USD 21.69 0.15 0.69% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 84.87610478 | Current Value 163.35 | Quarterly Volatility 356.19215398 |
Check Privia Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Privia Health's main balance sheet or income statement drivers, such as Net Interest Income of 7 M, Depreciation And Amortization of 3.3 M or Interest Expense of 8.8 M, as well as many indicators such as Price To Sales Ratio of 2.94, Dividend Yield of 0.0 or PTB Ratio of 4.55. Privia financial statements analysis is a perfect complement when working with Privia Health Valuation or Volatility modules.
Privia | Enterprise Value Over E B I T D A |
Latest Privia Health's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Privia Health Group over the last few years. It is Privia Health's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Privia Health's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Privia Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 465.62 | |
| Geometric Mean | 306.62 | |
| Coefficient Of Variation | 76.50 | |
| Mean Deviation | 330.74 | |
| Median | 741.24 | |
| Standard Deviation | 356.19 | |
| Sample Variance | 126,873 | |
| Range | 891 | |
| R-Value | (0.83) | |
| Mean Square Error | 41,427 | |
| R-Squared | 0.70 | |
| Significance | 0.0001 | |
| Slope | (66.48) | |
| Total Sum of Squares | 1.8M |
Privia Enterprise Value Over E B I T D A History
About Privia Health Financial Statements
Privia Health stakeholders use historical fundamental indicators, such as Privia Health's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Privia Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Privia Health's assets and liabilities are reflected in the revenues and expenses on Privia Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Privia Health Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 84.88 | 163.35 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Privia Health Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Privia Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Privia Health Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Privia Health Group Stock:Check out the analysis of Privia Health Correlation against competitors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Privia Health. If investors know Privia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Privia Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.38) | Earnings Share 0.11 | Revenue Per Share 14.435 | Quarterly Revenue Growth 0.049 | Return On Assets 0.0077 |
The market value of Privia Health Group is measured differently than its book value, which is the value of Privia that is recorded on the company's balance sheet. Investors also form their own opinion of Privia Health's value that differs from its market value or its book value, called intrinsic value, which is Privia Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Privia Health's market value can be influenced by many factors that don't directly affect Privia Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Privia Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Privia Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Privia Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.